NYSE - Nasdaq Real Time Price USD
Alto Neuroscience, Inc. (ANRO)
2.3300
+0.1300
+(5.91%)
As of 1:10:15 PM EDT. Market Open.
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
177,542
86,628
50,854
28,794
Total Liabilities Net Minority Interest
26,082
158,300
89,260
41,272
Total Equity Gross Minority Interest
151,460
-71,672
-38,406
-12,478
Total Capitalization
163,018
-61,811
-28,941
-12,478
Common Stock Equity
151,460
-71,672
-38,406
-12,478
Capital Lease Obligations
5,386
125
283
0
Net Tangible Assets
151,460
-71,672
-38,406
-12,478
Working Capital
159,329
79,781
43,660
25,874
Invested Capital
163,018
-61,811
-28,941
-12,478
Tangible Book Value
151,460
-71,672
-38,406
-12,478
Total Debt
16,944
9,986
9,748
0
Share Issued
26,968.1980
25,574.3600
25,574.3600
25,574.3600
Ordinary Shares Number
26,968.1980
25,574.3600
25,574.3600
25,574.3600
12/31/2021 - 2/2/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TIL Instil Bio, Inc.
14.63
+10.05%
AVBP ArriVent BioPharma, Inc.
19.16
+2.19%
RAPP Rapport Therapeutics, Inc.
9.72
+0.93%
KYTX Kyverna Therapeutics, Inc.
2.1550
+0.23%
NMRA Neumora Therapeutics, Inc.
0.6353
+3.28%
ALXO ALX Oncology Holdings Inc.
0.4304
-6.31%
BCAX Bicara Therapeutics Inc.
13.77
+0.51%
ERAS Erasca, Inc.
1.2092
-4.79%
CGON CG Oncology, Inc.
25.12
+3.93%
TYRA Tyra Biosciences, Inc.
9.72
+0.52%